What are the key nursing diagnoses for a patient with a UTI?

Key NANDA-I diagnoses for UTI include Infection (00004) or Risk for Infection related to urinary catheterization, Impaired Urinary Elimination (00016) related to urinary tract inflammation, Acute Pain (00132) related to bladder and urethral inflammation, Risk for Deficient Fluid Volume (00028) if the patient is febrile with poor oral intake, and Deficient Knowledge (00126) related to UTI prevention strategies. For elderly patients, Acute Confusion (00128) may be a priority diagnosis as altered mental status is often the presenting symptom of UTI in older adults.

How do UTI symptoms differ in elderly patients?

Elderly patients often present with atypical UTI symptoms. Instead of the classic dysuria, frequency, and urgency, older adults may present with acute confusion or delirium, increased falls, decreased appetite, functional decline, agitation, lethargy, or incontinence in a previously continent patient. Fever may be absent or blunted. This atypical presentation makes clinical suspicion and appropriate urinalysis testing essential for timely diagnosis and treatment in the geriatric population.

What catheter care should be included in a UTI prevention nursing plan?

Catheter-associated UTI (CAUTI) prevention includes: assess the need for the catheter daily and remove as soon as clinically possible (nurse-driven removal protocols), maintain a closed drainage system, perform catheter care with soap and water during bathing (not antiseptics per CDC), keep the drainage bag below the level of the bladder at all times, avoid dependent loops in the tubing, empty the drainage bag regularly without allowing the spigot to touch the collection container, secure the catheter to the thigh to prevent traction, maintain hand hygiene before and after catheter manipulation, and ensure at least 30 mL/hr urine output.

UTI (Urinary Tract Infection) Nursing Care Plan Example

Urinary tract infections are among the most common infections encountered in both community and hospital settings, and catheter-associated UTIs (CAUTIs) remain a significant healthcare-associated infection. This care plan example covers a hospitalized patient with a complicated UTI progressing to pyelonephritis, demonstrating NANDA-I diagnoses, NIC interventions, and NOC outcomes for infection management, pain control, hydration, and prevention education.

Condition Overview

A urinary tract infection involves microbial colonization and invasion of any structure in the urinary system. Lower UTIs (cystitis) affect the bladder and urethra, producing localized symptoms such as dysuria, frequency, urgency, and suprapubic discomfort. Upper UTIs (pyelonephritis) involve the kidneys and present with systemic symptoms including fever, chills, flank pain, nausea, and vomiting in addition to lower urinary symptoms. Escherichia coli is the causative organism in approximately 75-95% of uncomplicated UTIs.

Risk factors include female anatomy (short urethra), urinary catheterization (the single greatest risk factor for healthcare-associated UTI), urinary retention, diabetes mellitus, immunosuppression, pregnancy, menopause (estrogen decline), structural abnormalities (BPH, strictures), and recent urinary instrumentation. Complicated UTIs occur in the presence of structural or functional abnormalities, indwelling catheter, or systemic illness. Nursing plays a pivotal role in both treatment (medication administration, monitoring, symptom management) and prevention (catheter care, early catheter removal, patient education on hygiene and hydration).

Typical Patient Presentation

A patient with an uncomplicated lower UTI presents with dysuria (burning with urination), urinary frequency and urgency, suprapubic pain or pressure, cloudy or foul-smelling urine, and possibly hematuria. Vital signs are typically stable, and the patient does not appear systemically ill.

A patient with pyelonephritis or complicated UTI presents with the above symptoms plus fever (often above 101°F), chills and rigors, unilateral or bilateral costovertebral angle (CVA) tenderness, nausea and vomiting, tachycardia, and general malaise. In severe cases, signs of sepsis may be present (hypotension, altered mental status, tachycardia, elevated lactate). Elderly patients frequently present atypically with acute confusion, lethargy, falls, or functional decline without classic urinary symptoms, making diagnosis challenging. Laboratory findings include pyuria (WBC in urine), bacteriuria, positive urine culture, and in pyelonephritis, elevated WBC, elevated CRP, and possibly positive blood cultures.

Sample Assessment Scenario

Patient: Evelyn R., 78-year-old female, admitted from a skilled nursing facility with acute pyelonephritis. She was found to be acutely confused this morning (baseline: oriented x3, independent with ADLs). SNF staff noted a 2-day history of decreased appetite, new urinary incontinence, low-grade fever, and foul-smelling urine. PMH: Hypertension, T2DM, osteoarthritis, recurrent UTIs (3 in the past 12 months), urinary incontinence managed with incontinence briefs. She had an indwelling catheter during a hospitalization 6 weeks ago. Medications: metformin 500 mg BID, amlodipine 5 mg daily, acetaminophen 650 mg TID PRN. Vital signs on admission: BP 102/58, HR 104, RR 22, SpO2 97%, T 102.6°F. Assessment: Acutely confused (CAM positive for delirium), dry mucous membranes, poor skin turgor, right CVA tenderness, abdominal tenderness in the suprapubic region. Labs: WBC 16,400, UA positive for leukocyte esterase, nitrites, and bacteria, urine culture pending, serum creatinine 1.4 (baseline 0.9), lactate 2.2 mmol/L, blood glucose 246 mg/dL. Blood cultures x2 drawn. IV ceftriaxone 1g initiated. IV normal saline bolus 500 mL ordered, then 125 mL/hr.

NANDA-I Nursing Diagnoses

1. Infection (00004)

Definition: Invasion and multiplication of pathogenic organisms in body tissues that may be clinically apparent or subclinical.

Related factors: Bacterial invasion of the urinary tract, inadequate primary defenses (history of recurrent UTIs, recent catheterization, incontinence, diabetes mellitus, advanced age).

Evidence: Fever 102.6°F, WBC 16,400, positive UA (leukocyte esterase, nitrites, bacteria), right CVA tenderness, foul-smelling urine, elevated lactate 2.2 mmol/L, tachycardia.

2. Acute Confusion (00128)

Definition: Abrupt onset of reversible disturbances of consciousness, attention, cognition, and perception that develop over a short period.

Related factors: Infection (UTI/pyelonephritis), dehydration, electrolyte imbalance, fever, unfamiliar environment (hospitalization), advanced age.

Evidence: CAM positive for delirium, acute onset confusion (baseline oriented x3), inattention, altered level of consciousness.

3. Risk for Deficient Fluid Volume (00028)

Definition: Susceptibility to decreased intravascular, interstitial, and/or intracellular fluid volumes.

Risk factors: Fever (increased insensible losses), decreased oral intake (2-day history of decreased appetite), delirium limiting self-care, vomiting potential, hyperglycemia-induced osmotic diuresis.

Evidence: Dry mucous membranes, poor skin turgor, BP 102/58 (lower than expected for a hypertensive patient), tachycardia, elevated serum creatinine (1.4 vs baseline 0.9 suggesting prerenal AKI from dehydration).

4. Impaired Urinary Elimination (00016)

Definition: Dysfunction in urine elimination.

Related factors: Urinary tract infection causing bladder irritability, existing urinary incontinence exacerbated by infection, delirium limiting toileting ability.

Evidence: New urinary incontinence (worsened from baseline), frequent voiding per SNF report, suprapubic tenderness.

NIC Interventions

For Infection

Infection Protection (6550): Administer IV antibiotics on schedule (ceftriaxone 1g IV q24h). Ensure first dose is given within 1 hour of order (time-critical for sepsis criteria). Obtain urine and blood culture results and communicate to provider for antibiotic adjustment based on sensitivities. Monitor temperature every 4 hours. Administer antipyretics as ordered (acetaminophen 650 mg q6h for temp above 101°F). Monitor WBC trends daily. Track fever curve — expect defervescence within 48-72 hours of appropriate therapy. Report persistent fever or clinical deterioration.
Infection Control (6540): Practice strict hand hygiene before and after patient contact. Use standard precautions. Monitor for signs of sepsis progression (qSOFA criteria, lactate trends). Ensure urine cultures were obtained before antibiotics when possible. Monitor renal function daily (creatinine, BUN) — adjust antibiotic dosing for renal impairment if needed. Educate staff on perineal hygiene and incontinence care to prevent re-infection.

For Acute Confusion

Delirium Management (6440): Assess cognitive status using the CAM (Confusion Assessment Method) every shift. Identify and treat underlying causes (infection, dehydration, pain, medications). Provide reorientation cues: clock, calendar, familiar objects from SNF, consistent staff. Maintain day-night sleep cycle (lights on during the day, minimize nighttime disruptions). Avoid physical restraints (increase agitation and injury risk). Keep bed in lowest position with call bell within reach. Ensure eyeglasses and hearing aids are available and in use. Minimize unnecessary medications (review for deliriogenic agents: benzodiazepines, anticholinergics). Speak calmly with short, simple instructions. Include family or familiar caregivers when possible.

For Risk for Deficient Fluid Volume

Fluid Management (4120): Administer IV fluids as ordered (NS bolus then maintenance). Monitor strict intake and output hourly during acute phase. Encourage oral fluid intake as tolerated — offer preferred beverages frequently in small amounts. Target urine output at least 0.5 mL/kg/hr. Monitor for signs of overhydration in the elderly (crackles, edema) given aggressive IV fluids. Weigh patient daily. Monitor BUN, creatinine, and electrolytes daily — track creatinine for AKI resolution. Monitor blood glucose closely (hyperglycemia worsens dehydration via osmotic diuresis — administer insulin per sliding scale as ordered).
Fluid Monitoring (4130): Assess skin turgor and mucous membrane moisture every shift. Monitor orthostatic vital signs once patient can sit and stand. Track urine color and concentration (dark concentrated urine suggests continued dehydration). Monitor for signs of improving hydration (normalizing creatinine, improving mucous membranes, urine becoming lighter in color).

For Impaired Urinary Elimination

Urinary Elimination Management (0590): Avoid catheter insertion unless absolutely necessary (strict indications: acute urinary retention, accurate I&O measurement in critical illness). If a catheter is required, use a nurse-driven catheter removal protocol for earliest possible discontinuation. Implement a prompted voiding or timed toileting schedule (every 2 hours). Use incontinence pads with regular changes to maintain skin integrity. Perform perineal care after each episode of incontinence with gentle cleanser. Apply barrier cream to perineal skin. Monitor for urinary retention (bladder scan if no void for 6 hours).

NOC Outcomes

Infection Severity (0703)

Target: Temperature below 100.4°F within 48 hours of antibiotic initiation
Indicator: WBC trending toward normal range by day 3
Indicator: Lactate normalizing below 2.0 mmol/L within 24 hours
Indicator: Urine culture sensitivities confirm appropriate antibiotic coverage

Cognitive Orientation (0901)

Target: Delirium resolving (CAM negative) within 48-72 hours of infection treatment
Indicator: Patient returning to baseline orientation (oriented x3)
Indicator: Patient able to follow simple commands and engage in conversation

Fluid Balance (0601)

Target: Urine output at least 0.5 mL/kg/hr within 6 hours of IV fluid initiation
Indicator: Mucous membranes moist, skin turgor improving by day 2
Indicator: Serum creatinine trending back toward baseline (0.9) by discharge
Indicator: Blood pressure returning to patient baseline (expected hypertensive range)

Urinary Elimination (0503)

Target: Urinary frequency and urgency decreasing within 48 hours of antibiotic therapy
Indicator: Incontinence episodes returning to pre-infection baseline
Indicator: Urine clear and without foul odor by day 3-4

Discharge Planning Considerations

Discharge readiness includes afebrile for 24 hours, oral antibiotic transition tolerated, adequate oral intake, delirium resolved (or returning to baseline), renal function improving, and stable vital signs. For a patient returning to a skilled nursing facility, communicate the antibiotic course length, hydration goals, toileting schedule, and any changes to the care plan. Given the history of recurrent UTIs (3 in 12 months), discuss prevention strategies: adequate hydration (6-8 glasses of water daily), perineal hygiene (front-to-back wiping), prompt incontinence care, avoidance of unnecessary catheterization, and possible prophylactic strategies (discuss with provider — vaginal estrogen, cranberry products, or antibiotic prophylaxis). Follow up with the primary care provider within 1-2 weeks, with repeat urinalysis to confirm resolution.

Building Your Own UTI Care Plan

UTI care plans vary based on infection location (cystitis vs. pyelonephritis vs. urosepsis), patient age and comorbidities, catheter status, and whether the UTI is complicated or uncomplicated. This example addresses a complicated UTI with pyelonephritis in an elderly patient with delirium, but a younger patient with uncomplicated cystitis would have different priorities.

CarePlanHQgenerates individualized UTI nursing care plans from your assessment data. Enter the patient's urinary symptoms, vital signs, lab values, and risk factors to receive a complete NANDA-I care plan with interventions, outcomes, and a downloadable PDF.